OSA can lead to activation of the sympathetic nervous system, increased leptin and ghrelin levels contributing to increased appetite and food intake, decreased adiponectin level, oxidative stress, inflammation and obesity which all ultimately contribute to insulin resistance (49, 50). The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.